My watch list
my.bionity.com  
Login  

3,194 Current news from the ressort business

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
WACKER Invests in Amsterdam Biotech Site

The investment price is a mid-double-digit million-euro amount

30-Jul-2020

WACKER, the Munich-based chemicals Group, is investing in its production facilities for biologics, LMPs (live microbial products) and vaccines at its Amsterdam site. Projects include the construction of a new fermentation line with a volume of 1,500 liters as well as the setting up of new ...

more

image description
Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement

Offer price increased

17-Jul-2020

Thermo Fisher Scientific Inc. and QIAGEN N.V. announced that they have entered into an amendment to their acquisition agreement under which Thermo Fisher has commenced a tender offer to acquire all of the ordinary shares of QIAGEN. The amendment provides for an increase from the original offer ...

more

image description
Merck Invests € 18 Million in New Life Science Laboratory in Switzerland

Supports growing reference materials business

16-Jul-2020

Merck has announced plans to build a new, € 18 million laboratory facility in Buchs, Switzerland to support the company’s rapidly growing reference materials business. The company anticipates that about two dozen jobs will be created. "Researchers in testing labs around the world use Merck’s ...

more

image description
Merck Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech Grant

VAR2 Pharmaceuticals selected for its development of a drug-conjugated malaria protein

10-Jul-2020

Merck, a leading science and technology company, today announced that VAR2 Pharmaceuticals has been selected as the European winner of its 2020 Advance Biotech Grant Program. Copenhagen, Denmark-based biotechnology company VAR2 Pharmaceuticals was chosen for its development of a promising novel ...

more

image description
HepaRegeniX GmbH achieves successful proof of efficacy in acute liver disease models for selected MKK4 inhibitors

Reference to unique potential for the treatment of liver diseases

09-Jul-2020

HepaRegeniX GmbH, a preclinical stage company developing novel therapies for the treatment of acute and chronic liver diseases, announced today successful proof of efficacy for MKK4 inhibitors in several acute liver disease models. Underlying preclinical data showed strong inhibition of apoptosis ...

more

image description
Merck acquires a French company

Merck Advances Bioprocessing Capabilities with Raman Technology Sensor Acquisition

02-Jul-2020

Merck enhanced its advanced bioprocess portfolio through the acquisition of RESOLUTION Spectra Systems, a Meylan, France-based leader in bioprocess analytical monitoring. The company offers Raman spectroscopy analysis through its GMP-ready instrumentation and software. Financial details of the ...

more

image description
analytica 2020: Great exhibitor resonance for the autumnal fair

Trade fair to implement the government’s protection and hygiene concept

30-Jun-2020

After the postponement to the fall, there are now increasing signs for a success of analytica in October. The number of exhibitors has currently almost reached the level of the previous event. Most recently, the Bavarian State Government has cleared the way for analytica: From September 01 ...

more

image description
Novel virtual trade fair for the process industry

A new way to network and stay informed defies postponed or cancelled trade fairs: The "virtual process show" from 8 to 11 September 2020

22-Jun-2020

From 8 to 11 September 2020, LUMITOS, a leading provider of B2B specialist portals and online marketing solutions, will be hosting the "virtual process show", a new digital meeting place for the process industry. In the halls of the virtual process show, an expected more than 100 exhibitors from ...

more

image description
Development of novel proteasome inhibitors for treating cancer, inflammatory and autoimmune disorders

Launch of Start-up QLi5 Therapeutics

18-Jun-2020

The Lead Discovery Center GmbH (LDC) and the South Korean drug development specialist Qurient have founded QLi5 Therapeutics GmbH, together with their partners, the Max Planck Society (MPG) and Nobel laureate Prof. Huber, emeritus director of the Max Planck Institute for Biochemistry. Dortmund ...

more

image description
German Federal Government invests 300 Million Euros in CureVac

Federal Government will not influence corporate policy decisions

16-Jun-2020

The German Federal Minister for Economic Affairs and Energy, Peter Altmaier, and Dietmar Hopp, SAP co-founder and co-founder of the investment company dievini Hopp BioTech holding GmbH & Co. KG, announced today that the Federal Republic of Germany will invest 300 million Euros in the ...

more

Page 1 From 320
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE